Your browser doesn't support javascript.
loading
An Engineered Fusion Protein Anti-CD19(Fab)-LDM Effectively Inhibits ADR-Resistant B Cell Lymphoma.
Fan, Dongmei; Jiang, Linlin; Song, Yuewen; Bao, Shiqi; Yang, Yuanyuan; Yuan, Xiangfei; Zhen, Yongsu; Yang, Ming; Xiong, Dongsheng.
Afiliación
  • Fan D; State Key Laboratory of Experimental Hematology, Institute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Jiang L; School of Life Sciences, Ludong University, Yantai, China.
  • Song Y; State Key Laboratory of Experimental Hematology, Institute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Bao S; State Key Laboratory of Experimental Hematology, Institute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Yang Y; State Key Laboratory of Experimental Hematology, Institute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Yuan X; State Key Laboratory of Experimental Hematology, Institute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Zhen Y; Department of Oncology, Institute of Medicinal Biotechnology (IMB), Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Yang M; State Key Laboratory of Experimental Hematology, Institute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Xiong D; State Key Laboratory of Experimental Hematology, Institute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
Front Oncol ; 9: 861, 2019.
Article en En | MEDLINE | ID: mdl-31555598

Texto completo: 1 Colección: 01-internacional Idioma: En Revista: Front Oncol Año: 2019 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Idioma: En Revista: Front Oncol Año: 2019 Tipo del documento: Article País de afiliación: China